The oxygen paradox in retinopathy of prematurity: could fetal hemoglobin be the key?
-
By
-
Marcus T. A. Jackson
-
Ronny Amamoo
-
Menaka C. Thounaojam
-
Pamela M. Martin
-
Ravirajsinh N. Jadeja
-
June 2, 2026
-
Clinical Scorecard: The Role of Fetal Hemoglobin in the Oxygen Paradox of Retinopathy of Prematurity
At a Glance
| Category | Detail |
| Condition | Retinopathy of Prematurity (ROP) |
| Key Mechanisms | Postnatal decline in fetal hemoglobin (HbF) associated with increased ROP risk; transfusions from adult donors accelerate HbF replacement with adult hemoglobin (HbA). |
| Target Population | Preterm infants, particularly those between 31 and 34 weeks postmenstrual age. |
| Care Setting | Neonatal intensive care units. |
Key Highlights
- Lower HbF levels correlate with increased incidence and severity of ROP.
- Red blood cell transfusions from adult donors accelerate HbF decline.
- HbF's higher oxygen affinity may protect against hyperoxic injury in the retina.
- Transfusion practices significantly influence ROP risk.
- HbF levels can serve as predictive biomarkers for ROP risk.
Guideline-Based Recommendations
Diagnosis
- Monitor HbF levels in preterm infants to assess ROP risk.
Management
- Optimize transfusion practices to minimize HbF decline.
Monitoring & Follow-up
- Routine HbF monitoring as part of ROP preventive strategies.
Risks
- Increased risk of ROP associated with early and repeated transfusions.
Patient & Prescribing Data
Preterm infants, particularly those at risk for ROP.
Selective use of cord blood products and HbF-informed oxygen titration may mitigate ROP risk.
Clinical Best Practices
- Implement HbF stewardship to guide transfusion and oxygen management.
- Consider timing and frequency of transfusions to reduce ROP risk.
Related Resources & Content